Paracrine regulation of endometrial function: interaction between progesterone and corticotropin-releasing factor (CRF) and activin A

  title={Paracrine regulation of endometrial function: interaction between progesterone and corticotropin-releasing factor (CRF) and activin A},
  author={Pasquale Florio and Marco Rossi and Matthildur Sigurdardottir and Pasquapina Ciarmela and Stefano Vincenzo Luisi and Paola Vigan{\`o} and Daniel H. Grasso and Giovina Fiore and Luigi Cobellis and Annamaria Di Blasio and Felice Petraglia},

Figures from this paper

Interleukin 1β and Progesterone Stimulate Activin A Expression and Secretion From Cultured Human Endometrial Stromal Cells

The existence of a complex cross-talk by which the ovary, through Pr secretion, and the embryo, through IL-1β production, may trigger the endometrial induction of activin A and consequently timing implantation is suggested.

Immune function in pregnancy: the role of corticotropin-releasing hormone

The present article focuses on the potential roles of CRH on the physiology and pathophysiology of pregnancy and highlights its participation in implantation, early fetal immunotolerance and parturition.

Urocortins in human reproduction

Urocortin expression is downregulated in human endometrial carcinoma.

Evidence that endometrial cancer expresses UCN receptors and UCN is involved in tumorigenesis of several tissues together suggest a role for UCN inendometrial tumoral cell growth and proliferation.

Reviews: Activins and Related Proteins in the Establishment of Pregnancy

The local derangement of activin A pathway in some pregnancy disorders (incomplete and complete miscarriages, recurrent abortion, and ectopic pregnancy [EP]) further sustains the hypothesis thatactivin A and its related proteins play a relevant role in the establishment of pregnancy.

Chronic endometritis modifies decidualization in human endometrial stromal cells

The data suggests that CE modifies decidualization of human ESC through untuning the function of sex steroid hormone receptor.

Antagonizing the corticotropin releasing hormone receptor 1 with antalarmin reduces the progression of endometriosis

The first demonstration for the effective use on CRHR1 antagonist for the treatment of endometriosis with promising effects for long-term therapy of this debilitating disease is provided.

Effect of activin A on tumor necrosis factor-alpha/intercellular adhesion molecule-1 pathway in endometrial stromal cells.

Human Decidual Stromal Cells as a Component of the Implantation Niche and a Modulator of Maternal Immunity

The relationship between the decidualization of DSCs and pathological obstetrical and gynaecological conditions is discussed and the critical influence of D SCs on local immune cells populations as well as their relationship to the onset and maintenance of immune tolerance is described.



The decidualizing effect of progesterone may involve direct transcriptional activation of corticotrophin-releasing hormone from human endometrial stromal cells.

Evidence is provided that progesterone induces the transcription of CRH gene in human endometrial stroma, which coupled with the decidualizing properties of progester one and CRH may indicate that progestersone andCRH form a decidUALizing local pathway within the human endometricrium.

Corticotropin releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin

The Transcription of Corticotropin-Releasing Hormone in Human Endometrial Cells Is Regulated by Cytokines

The data suggest that IL-1 and IL-6 exert a strong stimulatory effect on the expression of endometrial CRH, which is most probably mediated via prostaglandins.

Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells.

This study demonstrates the synthesis and secretion of CRH by endometrial stromal cells at all phases of the menstrual cycle and demonstrates the expression of the CRH receptor R1 gene, which can be hypothesized that CRH contributes via autocrine/paracrine mechanisms toendometrial physiology.

Presence of immunoreactive corticotropin-releasing hormone in human endometrium.

The presence of CRH in the endometrium, and more specifically in the glandular epithelium during the proliferative and secretory phases of the menstrual cycle together with its known proinflammatory properties, suggest that this neuropeptide might participate in the inflammatory-like phenomena of endometrial physiology, such as menstrual shedding, surface epithelia repair, and/or implantation of the blastocyst.

Cycle and age-related changes in corticotropin-releasing hormone levels in human endometrium and ovaries

  • E. ZoumakisE. Chatzaki A. Gravanis
  • Biology
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2001
The concentration of immunoreactive CRH (ir-CRH) was significantly higher in the secretory phase of the menstrual cycle than the proliferative phase, suggesting that ovarian CRH is related to normal ovarian function during the reproductive lifespan.

Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues.

The present data show that local production of CRF-BP occurs in human trophoblast and intrauterine tissues and may represent one of the major mechanisms used by targets tissues to control CRF activity during pregnancy.

Expression and secretion of activin A: possible physiological and clinical implications.

The present review summarizes the various activin sources and functions in humans, and the data obtained on activin A measurement in various biological uids which suggest possible physiological and clinical implications.

Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF messenger ribonucleic acid.

Results indicate that human decidua is an intrauterine extrahypothalamic source of CRF in the maternal compartment and offer new tools to explore the in vitro decidualization processes and the regulation ofCRF release from decidUAL cells.